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Abstract
Sarcopenia and malnutrition are both commonly occurring conditions in elderly popula-
tion. As understood today, sarcopenia is a syndrome characterised by progressive and 
generalised loss of skeletal muscle mass, physical performance and/or strength, whereas 
malnutrition has been defined as a condition of an imbalance of energy, protein and 
other nutrients that can cause measurable negative effects. In many populations, mal-
nutrition and sarcopenia are present simultaneously, and they appear clinically through 
a combination of decreased body weight and nutrient intake, along with a decrease in 
muscle mass and function. Moreover, malnutrition is one of the key pathophysiological 
causes of sarcopenia. Both entities result in numerous and substantial negative outcomes 
to the patients and the healthcare system, including decreased quality of life and func-
tionality and increased healthcare costs, hospitalisation rates, morbidity and mortality. 
Early identification of sarcopenia would be of great clinical relevance because the loss of 
muscle mass and strength with ageing can be largely reversed by proper exercise and 
nutritional intervention. Clinicians should integrate nutritional assessment with sarco-
penia screening for optimal evaluation of these two interrelated issues to help improve 
clinical outcomes.
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1. Introduction
The aged population in the developed world is increasing rapidly. Ageing is accompanied 
by changes in body composition, including a decrease in muscle mass. From the age of 50 
years onwards, muscle mass decreases by 1–2% annually and muscle strength is reduced by 
approximately 1.5% annually between the age of 50 and 60 years [1]. This age-related loss of 
skeletal muscle mass, resulting in loss of strength and function, is defined as sarcopenia. This 
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geriatric syndrome is associated with an increased risk for adverse outcomes, such as poor 
quality of life, risk of falls and death. Moreover, it is a major contributing factor of physical 
disability, frailty and loss of independence in the elderly. It may be thus an important and 
potentially reversible cause of morbidity and mortality in older persons [2].
On the other hand, malnutrition is described as a chronic or acute condition of the body 
in which a deficiency or imbalance of energy, protein and other nutrients leads to negative 
effects on function, clinical outcomes and body composition [3].
Sarcopenia and malnutrition have similar physiological mechanisms and are common and 
overlapping in older adults. Both entities result in numerous and substantial negative out-
comes to the patients and the healthcare system, including decreased quality of life and func-
tionality and increased healthcare costs, hospitalisation rates, morbidity and mortality. Both 
entities are highly prevalent among population over the age of 65 years and more, especially 
in those living in nursing homes or hospitalised [4].
Early identification of sarcopenia and malnutrition would seem to be of clinical relevance 
because the nutritional deficiencies and the loss of muscle mass and strength with ageing can 
be largely reversed by proper lifelong improvements in nutritional intervention and physical 
activity. They are probably the most effective intervention to improve physical functioning, 
prevent falls and disabilities and, consequently, improve the quality of life in the older popu-
lation. This is especially important given that world is ageing and older adults will utilise 
healthcare services at an increased rate in the next years [4].
2. Sarcopenia
2.1. Definition, mechanisms, causes and prevalence of sarcopenia
The term sarcopenia is derived from the Greek words ‘sarx’ (flesh) and ‘penia’ (loss). Unlike 
earlier definitions of sarcopenia, focusing on measurements of low muscle mass only, the cur-
rent definition of sarcopenia according to the European consensus of the EWGSOP (European 
Working Group on Sarcopenia in Older People) [5] requires the presence of both low muscle 
mass and low muscle function (muscle strength or physical performance), although they 
have not achieved consensus on the cut-off points of muscle mass indicating sarcopenia. The 
International Working Group on Sarcopenia (IWGS) also proposed an operational definition 
of sarcopenia, which was targeted to individuals with functional decline, mobility-related dif-
ficulties, history of recurrent falls, recent unintentional weight loss, post-hospitalisation and 
chronic conditions [6, 7].
In many older people, sarcopenia is a multifactorial process where several mechanisms can 
be involved. When the only evident cause of sarcopenia is the ageing, sarcopenia can be con-
sidered as primary (or age-related). In fact, malnutrition status is one of the main causes of 
sarcopenia (protein-poor diet determines a compensatory response characterised by a reduc-
tion in lean mass) [8].
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Epidemiological data suggest that the prevalence of sarcopenia varies widely, depending on 
the different populations studied, gender, age, settings, diagnostic criteria used and the cut-
off points chosen to define a low muscle mass. In a recent systematic review [9], five European 
studies were found using EWGSOP criteria to define sarcopenia in ageing people using BIA 
(bioelectrical impedance analysis) in different settings, with a prevalence of sarcopenia 
between 7.5 and 77.6%. The highest prevalence was found in people staying in convalescence 
and rehabilitation units, while community-dwelling older people had the lowest prevalence.
3. Malnutrition
3.1. Definition and aetiology of malnutrition
Malnutrition has been defined as a condition of an imbalance of energy, protein and other 
nutrients that can cause measurable negative effects on body composition, physical function 
and clinical outcomes [10].
Older adults are known to be at high risk of malnutrition. Advanced age is an independent 
risk factor for malnutrition and is associated with a lower body weight, body mass index (BMI) 
and serum albumin. Malnutrition is not an inevitable side effect of ageing, but many changes 
associated with the process of ageing can promote a poor nutritional status. The decline in 
taste acuity and smell, poor dentition and a decreased appetite are some factors that can affect 
nutrient intake and can lead to malnutrition and its potentially serious consequences. Other 
factors, such as an increased frequency and severity of acute and chronic medical conditions, 
multiple medications, social or economic challenges and cognitive decline, all play a role in 
the aetiology of malnutrition among older adults [11].
3.2. Nutritional assessment in the elderly
The best validated and most widely used test to measure nutritional status of older people is 
the Mini Nutritional Assessment (MNA). This includes 18 questions regarding weight change, 
dietary change, gastrointestinal symptoms, mobility, physical assessment and disease and its 
relationship with nutritional requirements, with a maximum score of 30 points. Patients who 
score >24 points are considered well nourished, those that score 17–23.5 points are classified 
as at risk of malnutrition and those who score <17 points are considered malnourished. Using 
MNA, Guigoz found 5–71% prevalence of malnutrition among 6821 elderly persons after a 
review of 32 studies and reported that malnutrition risk was higher in those living in nursing 
homes than in community-dwelling elderly [12].
Another nutritional assessment tool developed for the elderly population is the Nutritional 
Form for the Elderly (NUFFE). This instrument was designed as a form that contains items 
that reflect functional, social, nutritional and health-related aspects of nutritional intake [13].
On the other hand, ESPEN (The European Society for Clinical Nutrition and Metabolism) 
has recently proposed a new consensus definition of malnutrition [14]. According to this 
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 definition, individuals identified as ‘at risk’ of malnutrition proceed in the diagnostic process, 
with two possible options: body mass index (BMI) <18.5 kg/m2 or unintentional weight loss 
(>10% independent of time or >5% in last 3 months), this last option is always combined with 
either a low BMI <20 kg/m2 (if <70 years old) or <22 kg/m2 (if >70 years old) or a low fat-free 
mass index (FFMI) <15 kg/m2 (women) and <17 kg/m2 (men).
3.3. Prevalence of malnutrition
Depending on the method or parameters used for the nutritional assessment, prevalence 
rates of malnutrition among elderly subjects range between 6.5 and 85%. Early identifica-
tion of older adults at nutritional risk, followed by adequate nutritional intervention, is 
expected to contribute to conservation of muscle function and muscle strength, and here-
with to maintenance the functional independence, the quality of life and possibly to prolong 
the survival [15].
The prevalence of malnutrition depends on multiple factors, including the definition and the 
diagnostic criteria used. This prevalence is greater among older adults in healthcare settings. 
In fact, in hospital settings, malnutrition is approximately 56% in elderly patients [16].
3.4. Malnutrition-sarcopenia syndrome
Malnutrition is common across varying patient populations, particularly in older adults, and 
sarcopenia prevalence also increases with age. Moreover, malnutrition is regarded as one 
important contributing factor in the complex aetiology of sarcopenia, and it may be amenable 
to intervention. In fact, a diagnostic category of malnutrition-related sarcopenia has been pro-
posed [5]. However, usually older people admitted to nursing homes are screened or assessed 
for either malnutrition or sarcopenia, but rarely for both conditions concurrently. In several 
populations, malnutrition and sarcopenia are present simultaneously and manifest clinically 
through a combination of decreased nutrient intake, decreased body weight, along with a 
decrease in muscle mass, strength and/or physical function [17].
Vanderwoude et al. [4] proposed the term ‘malnutrition-sarcopenia syndrome’, which embod-
ies the inherent association of both entities, highlighting their combined impact on clinical 
outcomes, including increased morbidity, infection and complications (as falls and disability), 
length of hospital stay and rehospitalisation rates, mortality and healthcare costs, apart from 
decreased quality of life. Malnutrition and sarcopenia are each independently associated with 
negative health consequences that impact older adults across healthcare settings [18, 19].
There are few published data demonstrating the co-occurrence of malnutrition and sarco-
penia in older adults. In a recent study [20], both entities have been studied in a post-acute 
care geriatric unit, applying the new ESPEN definition of malnutrition and EWGSOP criteria, 
assessing the potential clinical relationship between them. The prevalence of malnutrition 
in this population was 19.3%, and the prevalence of sarcopenia was significantly higher in 
patients with malnutrition: 82.3 versus 45.1% (p = 0.03), which means that most patients with 
sarcopenia fulfilled the ESPEN criteria for diagnosis of malnutrition. On the other hand, in 
the study of Senior et al. [21], sarcopenia was defined with EWGSOP criteria and  nutritional 
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 status was assessed with MNA short-form test. According to these criteria, 14.9% of par-
ticipants with sarcopenia were malnourished and 48.5% were at risk of malnutrition. The 
prevalence of malnutrition was higher in subjects with low handgrip strength (62.8%) and in 
participants with severe sarcopenia (60.8%). Moreover, research has shown that reductions in 
handgrip strength are common in individuals who have sarcopenia as well as in individuals 
who are malnourished [5, 22].
4. Screening for malnutrition-sarcopenia
Clinicians should integrate nutrition assessment with sarcopenia screening for optimal evalua-
tion of these two interrelated nutritional issues to help improve patients’ clinical outcomes [4].
For sarcopenia screening, a simple clinician tool has been suggested by the EWGSOP [5]. This 
group has developed an algorithm based on gait speed measurement (a cut-off point of >0.8 
m/s identifies risk for sarcopenia) as the easiest and most reliable way to begin sarcopenia 
screening in clinical practice.
Screening tools for malnutrition are intended for the quick identification of patients at risk 
of malnutrition, for more in-depth nutritional assessment, or for identifying patients at risk 
of developing complications or even increased risk of mortality. A variety of malnutrition 
screening tools are available such as the Malnutrition Screening Tool (MST), Malnutrition 
Universal Screening Tool (MUST) [23], the short form of the Mini Nutritional Assessment 
(SF-MNA) [24] and Nutrition Risk Screening-2002 (NRS-2002) [25]. Based on the evidence 
presented, the combination of screening and assessing for malnutrition and sarcopenia is rec-
ommended to screen for the presence of malnutrition-sarcopenia syndrome in at-risk patient 
populations, particularly older adults in clinical settings [4].
Clinicians are urged to screen, assess and treat these conditions currently. By examining 
aspects of both conditions, clinicians can more fully assess their patients’ clinical and nutri-
tional status and can design targeted therapies to meet their needs and improve outcomes [4].
Examining patient’s nutritional and functional status through screening and assessment for 
both malnutrition and sarcopenia will enable clinical practitioners to determine the presence 
of both entities in their patients and to target interventions to prevent and avoid them [4].
5. Nutritional interventions to prevent sarcopenia
The relationship between muscle mass, strength, physical function and nutritional status has 
significant clinical implications regarding the therapeutic approaches [26].
Early identification of sarcopenia would be of great clinical relevance because the loss of mus-
cle mass and strength with ageing can be largely reversed by proper exercise programs and 
nutritional intervention [27]. Of all the therapeutic options available, lifelong improvements in 
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physical activity and diet are probably the most effective public health intervention and the most 
important treatment option in nursing home residents for this condition, ongoing independence 
and autonomy in older people. The Society for Sarcopenia, Cachexia and Wasting Disease devel-
oped nutritional recommendations for the prevention and management of sarcopenia, which 
combined exercise with adequate protein and energy intake [28].
On the other hand, adequate caloric intake has to be considered as an essential requisite for any 
successful therapeutic approach in the institutionalised elderly participants, in terms of preven-
tion and treatment of sarcopenia. Nutrient intake, especially adequate amounts of high-quality 
protein and amino acids, is the most important anabolic stimulus of skeletal muscle protein syn-
thesis. Epidemiological studies suggest that a low protein intake is associated with sarcopenia. 
To prevent it, as optimal dietary protein intake, daily 1.0–1.2 g/kg with an optimal repartition 
over each daily meal or 25–30 g of high-quality protein per meal are recommended. Specifically, 
the amino acid leucine and meal-induced insulin, both independently stimulate muscle protein 
synthesis. It has been demonstrated that exercise and amino acid supplementation (3 g of a 
leucine-enriched balanced essential amino acid mixture twice a day) together may actually be 
effective in enhancing muscle strength, variables of muscle mass and walking speed in sarco-
penic women [29]. Antioxidants and ω 3-polyunsaturated fatty acids may also contribute to the 
preservation of muscle function. Low 25-hydroxyvitamin D (25(OH)D) serum level in adults 
is also a potentially modifiable risk factor for sarcopenia [30]. In fact, nutritional interventions 
combining adequate amounts of vitamin D and proteins are promising strategies to attenuate 
sarcopenia development [31]. Some studies have shown the effectiveness of other nutritional 
factors, such as cheese and milk protein and beta-hydroxy-beta-methylbutyrate (HMB), as a 
potential supplement to improve muscle quality in sarcopenic elderly people [32, 33].
In a recent study [34], Mediterranean dietary pattern (high in olive, low-fat dairy, vegetable, 
fish, nut and vegetable oil) has demonstrated a favourable role in the prevention of sarcopenia 
in postmenopausal women, in comparison with a Western pattern (based on high commercial 
beverage, sugar and dessert, snacks, solid fat, potato, high-fat dairy, legume, organ meat, fast 
food and sweets). Another study [35] demonstrated that improvements in clinically relevant 
measures, such as strength and functionality, could be achieved by supplementation with 
high-quality oral nutritional supplementation.
Other treatments of sarcopenia currently under investigation include testosterone replacement 
therapy, oestrogens in women, growth hormone and other behavioural and pharmacological 
strategies. The main limitation of these treatments is the lack of long-term adherence [8].
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